Clinical Trial Update: Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating carboplatin with paclitaxel poliglumex or paclitaxel in women with stage IIIB, stage IV, or recurrent non-small cell lung cancer; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Paclitaxel poliglumex (paclitaxel poliglumex)

Snippet

Sponsor: CTI BioPharma | Conditions: Lung Cancer | Phase 3 | Status: TERMINATED